Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for detecting abundance of mutant gene as well as compositions and application of mutant gene

A gene and point mutation technology, applied in the field of gene mutation abundance detection, can solve the problems of inability to judge the abundance of tumor-sensitive mutations and the reduction of drug efficacy

Active Publication Date: 2014-05-07
GENOSABER BIOTECH CO LTD +1
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For patients with low abundance of EGFR sensitive mutations taking targeted drugs, the effective rate of the drug will be significantly reduced, similar to the population without mutations
Qualitative detection can only give information about the presence or absence of mutations in genes, but cannot determine the abundance of sensitive mutations in tumors. Therefore, it is necessary to perform quantitative PCR detection of the abundance of mutated genes, so as to provide doctors with more comprehensive medication guidance information.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting abundance of mutant gene as well as compositions and application of mutant gene
  • Method for detecting abundance of mutant gene as well as compositions and application of mutant gene
  • Method for detecting abundance of mutant gene as well as compositions and application of mutant gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0070] Example 1, plasmid extraction and linearization enzyme digestion

[0071] Heat-shock transformed the required plasmid into E. coli DH5α, picked the monoclonal strain into 100ml LB medium (yeast extract 5g, protein jelly 10g, NaCl 10g, water 1000mL, pH7.4~7.6) the next day, and put it in 37 Cultivate overnight in an incubator at 180rpm / min. The cultured bacterial solution was centrifuged at 10,000 rpm / min to collect the bacterial cells, and the plasmid was extracted with HiSpeed ​​Plasmid Midi Kit (Qiagen), and the steps were performed according to the kit instructions. For the determination of the concentration of the extracted plasmid, use a microplate reader Spectrophotometer (Thermo Fisher) to measure the concentration at a wavelength of 260 nm, and take a certain amount to run agarose (0.7%) electrophoresis.

[0072] The extracted plasmid was single-digested with the restriction enzyme Xba I (the restriction site of Xba I is not included in the gene of interest) to...

Embodiment 2

[0077] Example 2. Quantitative Calibrators for Linearized and Circular Plasmids

[0078] Serial dilution and storage of linearized and circular plasmid standards: the dilution storage solution is TE-glycerol buffer (Tris-HCl0.1M, EDTA1mM, glycerol 20%, pH8.0).

[0079] Linearized plasmid standard gradient is: 10 5 , 10 4 , 10 3 , 10 2 , 10 copies / ul.

[0080] Circular plasmid standard gradient: 10 7 , 10 6 , 10 5 , 10 4 , 10 3 , 10 2 , 10 copies / ul.

[0081] The reaction system is shown in Table 4.

[0082] Table 4

[0083] components

Dosage (25ul reaction system)

2×Realtime PCR Master Mix

12.5ul

F-primer

300nM

R-primer

300nM

MGB fluorescent probe

100nM

plasmid

2ul

wxya 2 o

Replenish water to a volume of 25ul

[0084] After the PCR system is prepared, run the PCR on the machine, using the quantitative PCR instrument ABI-7300, and the PCR setting conditions are shown in Table 5....

Embodiment 3

[0089] Example 3, Quantitative Results of Linearized Plasmid and Circular Plasmid Standards on Cell Line Genome Mutant Genes

[0090] 3.1 Cell line genome extraction

[0091] KB, H1975, H1650, HCC827 and other cell lines use RPMI-1640+10%FBS medium, at 37°C, 5%CO 2 Cultured in an incubator, the cultured cells were extracted with the High Pure PCR Template Preparation Kit (Roche), and the operation was carried out according to the kit instructions. The concentration of the extracted gDNA was measured with a Spectrophotometer (Thermo Fisher), and the concentration of the corresponding mutant gene was adjusted to 2500 copy / ul. The mutations corresponding to the cell lines are shown in Table 6.

[0092] Table 6

[0093] EGFR gene mutation type

[0094] 3.2 Fluorescent PCR quantification

[0095] The known concentration of mutant gDNA of the cell line was determined by real-time fluorescent quantitative PCR of linearized and circular plasmid standard products, and th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Gradientaaaaaaaaaa
Gradientaaaaaaaaaa
Login to View More

Abstract

The invention relates to a method of detecting the abundance of a mutant gene as well as compositions and an application of the mutant gene. The invention discloses an improved method which can be used for carrying out PCR (Polymerase Chain Reaction) quantitative detection on the abundance of the mutant gene. According to the method, a detection standard substance is improved, and a linearized plasmid is used as a standard substance, so that the detection accuracy is obviously improved.

Description

technical field [0001] The invention belongs to the field of biotechnology; more specifically, the invention relates to a method, composition and application of gene mutation abundance detection. Background technique [0002] Molecularly targeted drugs have the advantages of clear targets, good curative effect, and relatively low side effects. In recent years, antitumor therapy using molecularly targeted drugs has attracted increasing attention. However, studies have shown that targeted drugs are not suitable for every tumor patient, and their efficacy is closely related to the gene mutation of a specific target. For example, the targeted drugs Gefitinib and Erlotinib for the treatment of non-small cell lung cancer target the epidermal growth factor receptor (EGFR); In the process of clinical trials and clinical applications, not all patients benefit, and only some patients have significant curative effect. This is mainly due to the correlation between the sensitive mutati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/11C12Q1/68
Inventor 杨国华何伟郭志伟李英辉
Owner GENOSABER BIOTECH CO LTD